{"url":"https://newsforagent.com/news/2026-11-03/organigram-acquires-aurora-cannabis","markdown_url":"https://newsforagent.com/news/2026-11-03/organigram-acquires-aurora-cannabis.md","title":"Organigram to Buy Aurora Cannabis for C$561 Million","headline":"Organigram Agrees to Acquire Aurora Cannabis at C$7.80 a Share, Valuing It at C$561 Million","description":"Organigram agreed to buy Aurora Cannabis for C$7.80 a share, valuing it at about C$561 million, a 93% premium to the August 10, 2026 unaffected price.","section":"Mergers & Acquisitions","published_at":"2026-11-03T14:32:39+00:00","modified_at":"2026-11-03T14:32:39+00:00","author":"News Desk","key_takeaways":["Organigram agreed to acquire all Aurora Cannabis shares at C$7.80 each, valuing Aurora at approximately C$561 million.","The price is a 93% premium to Aurora's August 10, 2026 unaffected price and 21% above Curaleaf's amended bid.","Organigram anticipates C$50 million in run-rate cost synergies, with closing expected in January 2027 subject to approvals."],"companies":[{"name":"OrganiGram","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00028z5/organigram","website":"http://organigram.ca"},{"name":"Aurora Cannabis","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0002xxv/aurora-cannabis","website":"https://auroramj.com"}],"source":{"publisher":"TradingView","title":"Organigram Global Inc. (OGI) to Acquire Aurora for C$561M","url":"https://www.tradingview.com/news/tradingview:8c4ad131a3866:0-organigram-global-inc-ogi-to-acquire-aurora-for-c-561m/"},"other_sources":[],"tags":["Mergers & Acquisitions","OrganiGram","Aurora Cannabis"],"body_markdown":"Organigram Global Inc. agreed to acquire all Aurora Cannabis shares at C$7.80 per share, valuing Aurora at approximately C$561 million, according to [TradingView](https://www.tradingview.com/news/tradingview:8c4ad131a3866:0-organigram-global-inc-ogi-to-acquire-aurora-for-c-561m/). The price is a 93% premium to Aurora's August 10, 2026 unaffected price and 21% above Curaleaf's amended bid.\n\n## Organigram's C$7.80 Cash-and-Shares Bid for Aurora\n\n[Organigram](https://akta.pro/company-profiles/00028z5/organigram) is Canada's largest licensed producer by recreational net revenue and market share, selling under brands including SHRED, BOXHOT and Edison across five Canadian facilities. [Aurora Cannabis](https://akta.pro/company-profiles/0002xxv/aurora-cannabis) is the target of the all-share offer, which values its fully diluted equity at approximately C$561 million.\n\nThe agreement sets consideration at C$7.80 per Aurora share. Organigram expects C$50 million in run-rate cost synergies after closing, and it expects the transaction to close in January 2027, subject to shareholder, regulatory and court approvals. Shareholder votes are expected in December 2026.\n\nThe bid follows Aurora's review of its options amid Curaleaf's hostile offer. Aurora said on October 8, 2026 that it had completed an expansion of its EU-GMP manufacturing facility in Leuna, Germany, renaming it Aurora Horizon, which more than doubles expected annual flower output, according to PR Newswire.\n\n## Organigram's Sanity Deal and BAT Funding\n\nOrganigram completed its acquisition of Sanity Group GmbH in April 2026 for €107.3 million upfront, made up of €78 million in cash and €29.3 million in shares, plus up to €113.8 million in earnout, according to akta.pro [company records](https://akta.pro/company-data). The same records show Organigram received more than C$345 million cumulatively from British American Tobacco across three tranches, with BAT's stake rising to about 48.4% after Sanity.\n\nOrganigram's full-year net revenue target exceeds C$300 million for fiscal 2026, the same records show.\n\n## Organigram's Path From Sanity to the Aurora Offer\n\nOrganigram announced in August 2026 the accelerated integration of Sanity Group under a unified global operating structure and appointed new leadership to oversee international expansion, Stock Titan reported. The Toronto Star reported the same month that the company posted record revenues after its acquisition of a European medical cannabis entity.\n\nIn September 2026, Organigram set its second Digital OG Investor Session for September 30 at 4:00 p.m. ET, featuring updates from senior leadership on global growth strategy, Stock Titan reported.\n\n## December Votes and January Closing\n\nAurora shareholders are expected to vote in December 2026, and the transaction's regulatory and court approvals are required before the expected January 2027 closing.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}